Changes are afoot at Abercrombie & Fitch, and they could signal an easier—and possibly more likely—buyout of the struggling teen retailer.
The company said Tuesday it will immediately terminate its shareholder rights plan, otherwise known as a poison pill and make changes to its board, including separating the roles of CEO and chairman.
CEO Mike Jeffries had served as its chairman since 1996, and will stay on as CEO and a member of the board. However, Abercrombie added three retail veterans to the board—former Sears CEO Arthur Martinez, Zale Chairman Terry Burman and former Avon CEO Charles Perrin. Martinez will take the chairman role.
Analysts reacted positively to the news, saying the actions show openness and responsiveness to change. The retailer's shares rose about 8 percent in early trading.
"We believe management's increasing willingness to change is a major long-term positive for every aspect of the business, as it will allow the company to be a more nimble player in a constantly changing teen space," said BMO Capital Markets analyst John Morris in a research note.
(Read more: No coal here! Retail's few winners)
Morris has an "outperform" rating on the stock, with a price target of $47. The shares are currently trading near $37. (Click here for the latest quote.)
Stifel Nicolaus analyst Richard Jaffe agreed that the moves are a step in the right direction, but noted that the retailer still has a way to go before restoring its margins to historical levels.
(Read more: Let go of the logos! Fast fashion's victims)
He said that Abercrombie is still challenged by the "diminished appeal of the brand and uninspired product," which will hold back its ability to significantly raise prices above current levels. As such, he retained his "hold" rating.
The retailer—along with the rest of the teen sector—was one of the most promotional during the past holiday season, offering 50 percent off the entire store.
Although Abercrombie has been struggling to gain traction in a competitive teen environment, particularly in the face of fast-fashion rivals such as H&M and Zara, it was one of the few retailers to beat expectations this holiday and raise its full-year forecasts. Still, its same-store sales were 6 percent lower for the nine weeks ended Jan. 4.
Abercrombie will report same-store sales for the month of January on Feb. 3, and fourth-quarter earnings later in the month. The retailer hasn't posted a comparable-sales gain since the first quarter of 2012.
—By CNBC's Krystina Gustafson. Follow her on Twitter @KrystinaGustafs.